Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis

Investigator Site #1022, Philadelphia

Investigator Site #1026, Rockville

Investigator Site #1043, Sandy Springs

Investigator Site #1035, Macon

Investigator Site #1025, Hialeah

Investigator site # 1028, Miami

Investigator site # 1030, Fort Lauderdale

Investigator Site # 1013, Tampa

Investigator Site # 1029, Birmingham

Investigator Site #1017, Owensboro

Investigator Site #1027, South Bend

Investigator Site # 1011, Columbus

Investigator Site #1010, Clarkston

Investigator Site #1031, New Brighton

Investigator Site # 1012, Rapid City

Investigator Site #1005, Rolling Meadows

Investigator SIte#1036, Overland Park

Investigator Site # 1023, Rogers

Investigator Site #1033, Norman

Investigator Site #1015, Houston

Investigator Site # 1006, San Antonio

Investigator Site # 1041, South Jordan

Investigator Site #1001, Phoenix

Investigator Site #1018, Los Angeles

Investigator Site #1007, Santa Monica

Investigator Site #1002, Sherman Oaks

Investigator Site #1021, Encinitas

Investigator Site #1019, Portland

Investigator Site #2001, Edmonton

Investigator Site # 2008, Surrey

Investigator Site #2003, Winnipeg

Investigator Site #2006, London

Investigator Site # 2004, Mississauga

Investigator Site # 2007, North Bay

Investigator Site #2005, Oakville

Investigator Site #2009, Toronto

Investigator Site # 2002, Waterloo

Investigator Site # 2010, Québec